Infosys near-term outlook weak, downside limited; MOFSL's Khemka positive on Fortis, renewables

Lumax Auto Tech Q4 profit jumps 51%; board approves stake buy in Lumax FAE

Auto components maker Lumax Auto Technologies reported a 51% year-on-year rise in consolidated net profit for the fourth quarter at ₹88.1 crore, compared with ₹58.4 crore in the corresponding period last year, aided by strong revenue growth and improved operating performance. 2 Min Read Continue Reading (Edited by : Prashant) First Published: May 29, 2026 7:31…

Read More
Olectra Greentech Q4 profit more than doubles to ₹56 cr on strong revenue, margins growth

Olectra Greentech Q4 profit more than doubles to ₹56 cr on strong revenue, margins growth

Olectra Greentech on Friday, May 29, reported a sharp rise in fourth-quarter earnings, with net profit more than doubling to ₹56 crore from ₹21 crore in Q4FY25, driven by strong revenue growth across its mobility and energy businesses. Revenue from operations rose 43.6% year-on-year to ₹644.7 crore compared with ₹448.9 crore a year ago. EBITDA…

Read More
FPI ownership in TSMC alone is double their holdings in Indian equities

FPI ownership in TSMC alone is double their holdings in Indian equities

TSMC nears $2 trillion valuation, driving Taiwan to fifth largest market and boosting growth, while Samsung and SK Hynix dominate Korea, raising concentration concerns. By Yoosef K   May 29, 2026, 7:51:29 PM IST (Updated) The blistering rally in shares of Taiwan Semiconductor Manufacturing Co. (TSMC) is pushing the company’s market capitalisation toward the $2 trillion…

Read More
Lupin arm to acquire 43.38% stake in Multicare Pharmaceuticals Philippines for US $39.6 m

Lupin gets US approval for colonoscopy prep drug, wins 180-day exclusivity

Lupin said it has received approval from the United States Food and Drug Administration (U.S. FDA) for its abbreviated new drug application for Sodium Sulfate, Magnesium Sulfate, and Potassium Chloride Tablets, 1.479 g/0.225 g/0.188 g. The company said the product is bioequivalent to the reference listed drug, Sutab tablets of Azurity Pharmaceuticals, Inc. Lupin added…

Read More
Chennai Petroleum Q4 Results: Net profit jumps 42%, revenue up 7%; dividend declared

Concord Biotech Q4 profit slides 37%, margins shrink; declares ₹7.55 dividend

Concord Biotech on Friday, May 29, reported a 36.8% drop in fourth-quarter earnings, with net profit falling to ₹88.8 crore from ₹140.4 crore in the corresponding quarter last year, impacted by lower revenue and margin contraction. The R&D-driven biopharmaceutical company said its revenue from operations declined 24.1% to ₹326.1 crore compared with ₹429.9 crore a…

Read More
SEBI imposes ₹29-crore penalties on Suzlon Energy and executives in OMS slump sale case

SEBI imposes ₹29-crore penalties on Suzlon Energy and executives in OMS slump sale case

Capital markets regulator Securities and Exchange Board of India (SEBI) on Friday (May 29) has imposed a total penalty of ₹15.95 crore on Suzlon Energy Ltd in a case involving alleged irregularities in the transfer of its operation & maintenance (OMS) business, financial statement misstatements, and related party transactions. The regulator also imposed penalties on…

Read More